Načítá se...
Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
Anticoagulation for cancer-associated venous thromboembolism (VTE) can be challenging due to complications—including bleeding and potential drug–drug interactions with chemotherapy—associated with vitamin K antagonists and inconvenience of low-molecular-weight heparin (LMWH). Direct oral anticoagula...
Uloženo v:
| Vydáno v: | Ann Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6594460/ https://ncbi.nlm.nih.gov/pubmed/30918939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdz111 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|